Liraglutide 3.0 emg efficacy and safety by baseline BMI in the SCALE Diabetes trial: post-hoc analysis

被引：0
|
作者：
Hemmingsson, J. Udden [1 ]
Rosenstock, J. [2 ]
Davies, M. [3 ]
Bays, H. [4 ]
Cancino, A. -P. [5 ]
Skjoth, T. V. [5 ]
Aroda, V. [6 ]
机构：
[1] Capio St Gorans Hosp, Stockholm, Sweden
[2] Diabet & Endocrine Ctr, Dallas, TX USA
[3] Univ Leicester, Leicester LE1 7RH, Leics, England
[4] L MARC Res Ctr, Louisville, KY USA
[5] Novo Nordisk, Soborg, Denmark
[6] MedStar Hlth Res Inst, Hyattsville, MD USA
来源：
DIABETOLOGIA | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
646
引用
收藏
页码：S311 / S311
页数：1
相关论文
共 50 条
  • [41] The relationship, structure and profiles of schizophrenia measurements: a post-hoc analysis of the baseline measures from a randomized clinical trial
    Lei Chen
    Glenn Phillips
    Joseph Johnston
    Bruce J Kinon
    Haya Ascher-Svanum
    Sara Kollack-Walker
    Paul Succop
    Dieter Naber
    BMC Psychiatry, 11
  • [42] Efficacy and safety of liraglutide 3.0 mg and 1.8 mg in weight loss responders vs non-responders in overweight/obese adults with Type 2 diabetes: a subgroup analysis of the SCALE Diabetes trial
    Davies, M. J.
    DeFronzo, R.
    Bergenstal, R.
    Kushner, R.
    Skjoth, T. V.
    Nzeakor, N.
    Mosenzon, O.
    DIABETIC MEDICINE, 2016, 33 : 65 - 65
  • [43] The magnitude of weight loss induced by metformin is independently associated with BMI at baseline in newly diagnosed type 2 diabetes: Post-hoc analysis from data of a phase IV open-labeled trial
    Zhou, Lingli
    Cai, Xiaoling
    Yang, Wenjia
    Han, Xueyao
    Ji, Linong
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 26 (04): : 671 - 677
  • [44] Efficacy and Safety of Galcanezumab as a Preventive Treatment for Episodic Migraine in South Korean Patients: A Post-Hoc Analysis of a Phase 3 Clinical Trial
    Kim, Byung-Kun
    Cho, Soo-Jin
    Han, Jeong Hee
    Dell'Agnello, Grazia
    Panni, Tommaso
    Kim, Manho
    Oh, Kyungmi
    Moon, Heui-Soo
    Chu, Min Kyung
    JOURNAL OF CLINICAL NEUROLOGY, 2023, 19 (05): : 483 - 494
  • [45] Role of Concomitant Immunosuppression in the Efficacy and Safety of Ustekinumab: Post-Hoc Analyses of UNITI
    Hanauer, Stephen
    Sattin, Bernie
    Jacobstein, Douglas
    Gao, Long-Long
    Gasink, Christopher
    Rutgeerts, Paul
    Ghosh, Subrata
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S63 - S63
  • [46] Semaglutide 2.4 mg in People With or Without Antidepressants at Baseline: A Post-Hoc Analysis
    Kushner, Robert
    Fink-Jensen, Anders
    Frenkel, Ofir
    McGowan, Barbara
    Iversen, Aske Thorn
    Overvad, Maria
    Wadden, Thomas
    OBESITY, 2023, 31 : 32 - 33
  • [47] Post-hoc analysis of a randomized controlled trial: Diabetes mellitus modifies the efficacy of the 13-valent pneumococcal conjugate vaccine in elderly
    Huijts, Susanne M.
    van Werkhoven, Cornelis H.
    Bolkenbaas, Marieke
    Grobbee, Diederick E.
    Bonten, Marc J. M.
    VACCINE, 2017, 35 (34) : 4444 - 4449
  • [48] Effect of Once-Weekly Dulaglutide 3.0 and 4.5 mg in Patients with Different Baseline Renal Function: Post-hoc Analysis from the Award-11 Trial
    Garcia-Perez, Luis-Emilio
    Maldonado, Juan M.
    Ranta, Kari T.
    Raha, Sohini
    DIABETES, 2021, 70
  • [49] Efficacy and Safety of Etanercept in Elderly Patients with Rheumatoid Arthritis: A Post-Hoc Analysis of Randomized Controlled Trials
    Edwards, Christopher J.
    Roshak, Katherine
    Bukowski, Jack F.
    Pedersen, Ronald
    Thakur, Mazhar
    Borlenghi, Cecilia
    Curiale, Cinzia
    Jones, Heather
    Marshall, Lisa
    DRUGS & AGING, 2019, 36 (09) : 853 - 862
  • [50] Efficacy and Safety of Etanercept in Elderly Patients with Rheumatoid Arthritis: A Post-Hoc Analysis of Randomized Controlled Trials
    Christopher J. Edwards
    Katherine Roshak
    Jack F. Bukowski
    Ronald Pedersen
    Mazhar Thakur
    Cecilia Borlenghi
    Cinzia Curiale
    Heather Jones
    Lisa Marshall
    Drugs & Aging, 2019, 36 : 853 - 862
12345